Market Place
Sourcing Support
Wave Life Sciences Sets July 30, 2025, for Second Quarter 2025
23 Jul 2025 //
GLOBENEWSWIRE
Wave Life Sciences Announces Preclinical Data on WVE-007 at ADA
20 Jun 2025 //
GLOBENEWSWIRE
Wave Life Sciences Reports Positive Results in SELECT-HD Trial
25 Jun 2024 //
GLOBENEWSWIRE
Wave Life Sciences to Present at 2024 Jefferies Global Healthcare Conference
30 May 2024 //
GLOBENEWSWIRE
Wave Appoints Dr. Erik Ingelsson As Chief Scientific Officer
09 May 2024 //
GLOBENEWSWIRE
Wave Life Sciences Q1 2024 Financials And Business Update
09 May 2024 //
GLOBENEWSWIRE
Wave Life Sciences To Present At 2024 RBC Healthcare Conference
07 May 2024 //
GLOBENEWSWIRE
Wave Life Q1 2024 Results On May 9
02 May 2024 //
GLOBENEWSWIRE
Wave Updates GSK RNAi Collaboration, RNA Editing Progress
23 Apr 2024 //
GLOBENEWSWIRE
Wave Life Sciences to Present at Upcoming Investor Conferences
27 Mar 2024 //
GLOBENEWSWIRE
Wave Life Sciences Reports Fourth Quarter and Full Year 2023 Financial Results
06 Mar 2024 //
GLOBENEWSWIRE
Wave Life Q4 and Full Year 2023 Financial Results Scheduled for March 6, 2024
28 Feb 2024 //
GLOBENEWSWIRE
Wave Life Sciences Announces Upcoming Presentations at MDA Conference
27 Feb 2024 //
GLOBENEWSWIRE
Wave Life Sciences Highlights Recent Achievements and Upcoming 2024 Milestones
08 Jan 2024 //
GLOBENEWSWIRE
Wave Life Sciences to Present at 42nd Annual J.P. Morgan Healthcare Conference
03 Jan 2024 //
GLOBENEWSWIRE
Wave makes $100M offering after dosing first subjects with RNA editing drug
07 Dec 2023 //
ENDPTS
Wave Life Announces Initiation of Dosing in RestorAATion Clinical Program
06 Dec 2023 //
GLOBENEWSWIRE
Wave Life Sciences Announces Proposed Public Offering of Ordinary Shares
06 Dec 2023 //
GLOBENEWSWIRE
Wave Life Sciences to Present at 6áµ Annual Evercore ISI HealthCONx Conference
22 Nov 2023 //
GLOBENEWSWIRE
Wave Life Sciences Reports Third Quarter 2023 Financial Results
09 Nov 2023 //
GLOBENEWSWIRE
Wave Life Third Quarter 2023 Financial Results Scheduled for November 9, 2023
03 Nov 2023 //
GLOBENEWSWIRE
Wave Life Sciences to Present at the Chardan 7th Annual Conference
25 Sep 2023 //
GLOBENEWSWIRE
Wave Life Sciences to Present at H.C. Wainwright 25th Annual Global Conference
06 Sep 2023 //
GLOBENEWSWIRE
Wave readies clinical testing for first RNA editing therapy
06 Sep 2023 //
PRESS RELEASE
Wave Life Sciences Reports Second Quarter 2023 Financial Results
03 Aug 2023 //
GLOBENEWSWIRE
Wave Life Sciences Q2 2023 Financial Results Scheduled for August 3, 2023
27 Jul 2023 //
GLOBENEWSWIRE
Wave Life Sciences Joins the Russell 2000® and Russell 3000® Indexes
26 Jun 2023 //
GLOBENEWSWIRE
Wave Life Sciences to Highlight Leading RNA Editing Capability & Discovery
16 May 2023 //
GLOBENEWSWIRE
Wave Life Sciences Reports 1Q 2023 FYR and Provides Business Update
03 May 2023 //
GLOBENEWSWIRE
Wave Life Sciences 1Q 2023 FYR Scheduled for May 3, 2023
26 Apr 2023 //
GLOBENEWSWIRE
Wave Life Sciences Reports Fourth Quarter and Full Year 2022 Financial Results
22 Mar 2023 //
GLOBENEWSWIRE
Wave Life to Webcast Conference of Q4 and Full Year 2022 Financial Results
02 Mar 2023 //
GLOBENEWSWIRE
Wave Life Sciences to Present at the 2023 Virtual SVB Securities Conference
09 Feb 2023 //
GLOBENEWSWIRE
Wave Life Provides Positive Update on Proof-of-Concept Study for WVE-N531
19 Dec 2022 //
GLOBENEWSWIRE
GSK Strikes $3.3B Oligonucleotide Pact with Wave Life Sciences
14 Dec 2022 //
BIOSPACE
Wave Life Sciences to Present at the Stifel 2022 Healthcare Conference
09 Nov 2022 //
GLOBENEWSWIRE
Wave Life Sciences to Webcast Conference Call of 3Q FYR on November 10, 2022
03 Nov 2022 //
GLOBENEWSWIRE
Wave Life Sciences to Highlight Advancements from PRISM Platform
03 Oct 2022 //
GLOBENEWSWIRE
Wave Life Sciences Highlights Therapeutic Potential for WVE-006 f
28 Sep 2022 //
GLOBENEWSWIRE
Wave Life Sciences to Present at Chardan’s 6th Annual Genetic Medicines
27 Sep 2022 //
GLOBENEWSWIRE
Wave Life Sciences Announces Positive Update from Phase 1b/2a SELECT-HD
20 Sep 2022 //
GLOBENEWSWIRE
Wave Life Sciences Reports Second Quarter 2022 Financial Results
11 Aug 2022 //
PRESS RELEASE
Wave Life Sciences to Webcast Conference Call of Q2 2022 Financial Results
28 Jul 2022 //
GLOBENEWSWIRE
Ra Capital Management raises passive stake in Wave Life Sciences
22 Jun 2022 //
SEEKING ALPHA
Wave Life Sciences Announces Pricing of $70.0 Million Underwritten Offering
14 Jun 2022 //
GLOBENEWSWIRE
Wave Life Sciences to Present at the 2022 Jefferies Healthcare Conference
25 May 2022 //
GLOBENEWSWIRE
Wave Life Sciences Reports First Quarter 2022 Financial Results
12 May 2022 //
GLOBENEWSWIRE
Wave Life Sciences to Present at Upcoming Investor Conferences
10 May 2022 //
GLOBENEWSWIRE
Wave Life Sciences to Webcast Conference Call of Q1 2022 Financial Results
05 May 2022 //
GLOBENEWSWIRE
Wave Life Sciences Announces Publication of Foundational Preclinical Data
25 Apr 2022 //
GLOBENEWSWIRE
Wave Life Sciences to Present at Chardan`s Summit
19 Apr 2022 //
GLOBENEWSWIRE
Wave Life Sciences Shows Positive Update to Ongoing Phase 1b/2a FOCUS-C9 Study
04 Apr 2022 //
GLOBENEWSWIRE
Wave Life Sciences to Present at Stifel 2022 CNS Days
21 Mar 2022 //
GLOBENEWSWIRE
Extendicare says March 2022 Dividend of C$0.04 per Share
15 Mar 2022 //
GLOBENEWSWIRE
Wave Life Sciences: Nature Bio Publication Showing RNA Base Editing
07 Mar 2022 //
GLOBENEWSWIRE
Wave Life Sciences Reports Fourth Quarter and Full Year 2021 Financial Results
03 Mar 2022 //
GLOBENEWSWIRE
Wave Life Sciences to Webcast Call of Q4 and Full Year 2021 Financial Results
24 Feb 2022 //
GLOBENEWSWIRE
Wave Life Sciences to Present at Virtual 11th Annual SVB Leerink Conference
09 Feb 2022 //
GLOBENEWSWIRE
Wave Life Sciences to Webcast Conference Call of Third Quarter 2021
01 Nov 2021 //
GLOBENEWSWIRE
Takeda crashes out of Wave discovery pact at cost of $23M
20 Oct 2021 //
FIERCEBIOTECH
